2,6-diisopropylphenyl-4-hydroxybutanote disodium phosphate

Known as: HX0969w 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2011-2015
01220112015

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
OBJECTIVE To estimate the median effective dose (EDs0) of oral administrated HX0969w, fospropofol disodium and propofol emulsion… (More)
Is this relevant?
2014
2014
BACKGROUND Phosphate ester prodrugs of propofol (fospropofol, HX0969W) were designed to avoid the unsatisfactory water solubility… (More)
  • figure 1
  • figure 3
  • figure 4
  • figure 5
  • table 1
Is this relevant?
2013
2013
BACKGROUND HX0969w is a novel water-soluble prodrug designed to release propofol and gamma-hydroxybutyrate (GHB) and has a… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Is this relevant?
2013
2013
The water-soluble derivatives of propofol have gained attention as a method to increase solubility of propofol. According to the… (More)
  • table 1
  • figure 6
  • figure 1
  • table 2
  • figure 4
Is this relevant?
2011
2011
HX0969w is a novel carboxylate ester prodrug of propofol. After intravenous administration of HX0969w, the compound is rapidly… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • table 2
Is this relevant?